Tejus Chiranjeevi

HCG Cancer Hospital

Papers

1

Total Citations

1

H-Index

1

About

Dr. Tejus Chiranjeevi is a pioneering urologic surgeon whose work centers on advancing nerve-sparing techniques in robot-assisted radical prostatectomy (RARP), with a particular focus on improving oncologic and functional outcomes for prostate cancer patients. His most notable contribution is the adaptation and validation of the Neurovascular Structure-Adjacent Frozen-Section Examination (NeuroSAFE) technique in the Indian clinical context. In his 2024 landmark study, Dr. Chiranjeevi demonstrated the feasibility and early outcomes of this intraoperative frozen-section analysis, which allows surgeons to preserve neurovascular bundles more precisely while ensuring complete cancer resection. Although his work is early in its citation trajectory, its clinical significance is profound—offering a pathway to reduce positive surgical margins and preserve erectile function in a resource-constrained setting. By tailoring a sophisticated Western protocol to Indian surgical realities, Dr. Chiranjeevi has laid the groundwork for broader adoption of neurovascular-sparing RARP, potentially improving quality of life for thousands of patients. His research bridges the gap between technical innovation and practical implementation, marking him as an emerging leader in urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Neurovascular Structure-Adjacent Frozen-Section Examination (NeuroSAFE) Technique of Nerve-Sparing Robot-Assisted Radical Prostatectomy (RARP) in Indian Scenario: Technique, Feasibility, and Early Outcomes
1 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: HCG Cancer Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago